CRISPR Cell And Gene Therapies: Key Challenges In Clinical Development

The long-held promise of cell and gene therapy is finally a reality. Recent improvements in our understanding of human genome, combined with advances in genome engineering technology, have resulted in a groundswell of innovation in the cell and gene therapy field.

One of these innovations is Clustered Regularly Interspaced Short Palindromic Repeats, known as CRISPR. CRISPR is a gene editing technique that completely inactivates genes by acting on target DNA. Learn more about Synthego solutions to CRISPR cell and gene therapy development such as:

• Regulatory hurdles
• Ensuring consistency
• Finding qualified and experienced staff
• Obtaining GMP-Grade reagents

Download this E-book below and check out the rest of Synthego's Preclinical Resource Collection:

• Discovery To Clinic: CRISPR-Based Therapies And Diagnostics
• CRISPR Clinical Trials And Regulatory Approval Of CRISPR Therapy Drugs
• INDe sgRNAs For Preclinical Safety, Toxicity, And Efficacy Studies

As well as our Clinical Resource Collection:

• CRISPR Clinical Trials And Regulatory Approval Of CRISPR Therapy Drugs
• GMP sgRNA Manufacturing For Seamless Transitions From Discovery To Delivery
• New Next-Generation GMP Facility